Clinical trial
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the…
NCT00345033 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00345033 |
|---|---|
| Title | Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia |
| Official title | Aripiprazole for Clozapine Associated Medical Morbidity |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Insulin Resistance |
| Intervention type | Drug |
| Interventions | Aripiprazole, Placebo |
| Enrollment | 38 |
| Start date | Mar 1, 2005 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2010 |
| First posted | Jun 27, 2006 |
| Last update posted | Jun 23, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: